Multiplikator Forward P/S: iSpecimen Inc (ISPC)

iSpecimen Inc. (ISPC) is developing a scalable digital hub for biomaterial exchange, extracting profit from every transaction without incurring infrastructure costs. The GURU.Markets service features a linear chart of the forward price-to-sales multiple, where 3.70 represents the current level of the metric. This confirms the company's pricing power derived from its unique access to rare samples. The brand's impeccable ethical standing guarantees the trust of the world's leading laboratories.

Forward P/S determines the market value of one dollar of expected revenue, allowing for an assessment of the asset's current level of overvaluation or discount relative to historical averages. The current value of 3.70 based on the projected P/S reflects market expectations for scaling the commission income of the biospecimen marketplace iSpecimen Inc. (ISPC), serving as an indicator of the business's fundamental stability amid growing demand for medical research.